Semaglutide and liraglutide are associated with a reduced risk for hospitalization due to alcohol use disorder (AUD).

COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage is low among adults so far this respiratory virus season (2024 to 2025).

Mortality risk, especially due to dermatological and endocrine causes, was higher among patients with type 1 diabetes compared with type 2 diabetes.

Digital health tools have the potential to improve health outcomes among individuals with IBS, but more research is needed.

Younger and middle-aged patients seem to be disproportionately affected by neurologic manifestations of postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection (Neuro-PASC).

An estimated 100,429 youth are living with pediatric inflammatory bowel disease (PIBD) in the United States, according to a research letter.